# FDA Inspection 1253933 - Navin Kasliwal, Dr. - October 17, 2024

Source: https://www.keypedia.com/records/fda_inspections/navin-kasliwal-dr/7eee634a-1130-49ef-96f1-9b7f94acb786
Source feed: FDA_Inspections

> FDA Inspection 1253933 for Navin Kasliwal, Dr. on October 17, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1253933
- Company Name: Navin Kasliwal, Dr.
- Inspection Date: 2024-10-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1253933 - 2024-10-17](https://www.keypedia.com/records/fda_inspections/navin-kasliwal-dr/539caab5-6906-4589-b0e5-8bf076f4af71)

Company: https://www.keypedia.com/companies/navin-kasliwal-dr/6dd2bee7-47b4-452c-81a0-5a4828bbf2f6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c